Reduced nicotine content cigarettes and nicotine patch

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 6, 2013, Pages 1015-1024

  Hatsukami, Dorothy K ^a,b,c,d   Hertsgaard, Louise A ^a   Vogel, Rachel I ^c   Jensen, Joni A ^a,b   Murphy, Sharon E ^a,c   Hecht, Stephen S ^a,c   Carmella, Steven G ^c   Al'Absi, Mustafa ^e   Joseph, Anne M ^b   Allen, Sharon S ^a,d  

^a Tobacco Research Programs   (United States)

^b Department of Psychiatry ^*  (United States)

^c Department of Laboratory Medicine and Pathology Masonic Comprehensive Cancer Center   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

^e Departments of Family Medicine and Community Health and Behavioral Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CREATININE; NICOTINE; NICOTINE PATCH;

ADULT; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MARKER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REDUCED NICOTINE CONTENT CIGARETTE; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO DEPENDENCE; TREATMENT RESPONSE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; NICOTINIC AGONISTS; PROGNOSIS; SMOKING CESSATION; TOBACCO PRODUCTS; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84879018763     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-1439     Document Type: Article

References (25)

1. Benowitz NL, Henningfield JE. Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med 1994;331:123-5. (Pubitemid 24202231)
2. Hatsukami D, Perkins KA, Lesage MG, Ashley DL, Henningfield JE, Benowitz NL, et al. Nicotine reduction revisited: science and future directions. Tob Control 2010;19:e1-10.
3. Walker N, Howe C, Bullen C, Grigg M, Glover M, McRobbie H, et al. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial. Addiction 2012;107: 1857-67.
4. Benowitz NL, Hall SM, Stewart S, Wilson M, Dempsey D, Jacob P III. Nicotine and carcinogen exposure with smoking of progressively reduced nicotine content cigarette. Cancer Epidemiol Biomarkers Prev 2007;16:2479-85. (Pubitemid 351196384)
5. Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev 2012;21: 761-9.
6. Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 2010;105: 343-55.
7. Stepanov I, Jensen J, Hatsukami D, Hecht SS. Tobacco-specific nitrosamines in new tobacco products. Nicotine Tob Res 2006;8: 309-13. (Pubitemid 43675085)
8. Fiore MC, Jaen CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 2008.
9. Jacob P III, Byrd GD. Use of chromatographic and mass spectrometric techniques for the determination of nicotine and its metabolites. In: Gorrod JW, Jacob P III, editors. Analytical determination of nicotine and related compounds and their metabolites. Amsterdam: Elsevier; 1999. p. 191-224.
10. Hecht SS, Carmella SG, Murphy SE. Effects of watercress consumption on urinary metabolites of nicotine in smokers. Cancer Epidemiol Biomarkers Prev 1999;8:907-13. (Pubitemid 29508727)
11. Carmella SG, Han S, Fristad A, Yang Y, Hecht SS. Analysis of total 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine. Cancer Epidemiol Biomarkers Prev 2003;12: 1257-61. (Pubitemid 37499454)
12. Hatsukami D, McBride C, Pirie P, Hellerstedt W, Lando H. Effects of nicotine gum on prevalence and severity of withdrawal in female cigarette smokers. J Subst Abuse 1991;3:427-40.
13. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal: a replication and extension. Arch Gen Psychiatry 1991;48:52-9.
14. Hughes JR, Hatsukami D. Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry 1986;43:289-94. (Pubitemid 16052281)
15. Hatsukami D, Anton D, Keenan R, Callies A. Smokeless tobacco abstinence effects and nicotine gum dose. Psychopharmacology (Berl) 1992;106:60-6.
16. Hatsukami D, Huber M, Callies A. Physical dependence on nicotine gum: effect of duration on use. Psychopharmacology 1993;111: 449-56. (Pubitemid 23205669)
17. Hatsukami D, Gust SW, Keenan RM. Physiologic and subjective changes from smokeless tobacco withdrawal. Clin Pharmacol Ther 1987;41:103-7. (Pubitemid 17008137)
18. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addict 1991;86: 1119-27.
19. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1: 385-401.
20. Donny EC, Jones M. Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine. Drug Alcohol Depend 2009;104: 23-33.
21. Rose JE, Behm FM, Westman EC, Kukovich P. Precessation treatment with nicotine skin patch facilitates smoking cessation. Nicotine Tob Res 2006;8:89-101.
22. Rezaishiraz H, Hyland A, Mahoney MC, O'Connor RJ, Cummings KM. Treating smokers before the quit date: can nicotine patches and denicotinized cigarettes reduce cravings? Nicotine Tob Res 2007;9:1139-46. (Pubitemid 350066230)
23. Becker KM, Rose JE, Albino AP. A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation. Nicotine Tob Res 2008;10: 1139-48. (Pubitemid 352044699)
24. Rose JE. Nicotine and non nicotine factors in cigarette addiction. Psychopharmacology (Berl) 2006;184:274-85. (Pubitemid 43255844)
25. Benowitz N. Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. Clin Pharmacol Ther 2008;83:531-41. (Pubitemid 351417076)